A post-marketing surveillance study of fosfomycin sodium for injection - A nationwide prospective study of safety in 100,000 cases

Japanese Journal of Chemotherapy

Volumn 48, Issue 11, 2000, Pages 851-879

  Kawabata, T ^a   Yokota, M ^a   Mayama, T ^a   Shimizu, K ^a  

^a MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

Anaphylactic shock; FOM Na; Fosfomycin sodium; Prospective study

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; FOSFOMYCIN SODIUM; FOSMICIN S; HABEKACIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANAPHYLACTIC SHOCK; BILIARY TRACT DISEASE; CHILD; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INJECTION; KIDNEY DISEASE; LIMB DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; POSTMARKETING SURVEILLANCE; REVIEW; SKIN DISEASE;

EID: 0033676485     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever
2. Drug allergy
3. β-Lactam allergy
4. Medical myth. Ten percent of patients who are allergic to penicillin will have serious reactions if exposed to cephalosporins